These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8129570)

  • 1. Early changes in the plasma proteins of patients treated with low doses of oral natural human interferon alpha (IFN-alpha).
    Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):259-65. PubMed ID: 8129570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
    Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral hepatitis B.
    Georgiades JA; Caban J; Zyrkowska-Bieda T; Zejc M; Jonas-Skulina U; Cieśla A
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):187-94. PubMed ID: 8915525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of acute and chronic viral hepatitis.
    Hoofnagle JH
    Adv Intern Med; 1994; 39():241-75. PubMed ID: 8140956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural human interferon alpha may act differently when given parenterally or orally to patients chronically infected with hepatitis B virus.
    Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):11-22. PubMed ID: 8874764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
    J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
    Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.
    Maruyama S; Hirayama C; Horie Y; Yorozu K; Maeda K; Inoue M; Fujii Y; Umeki K; Koda M
    Hepatogastroenterology; 2007 Mar; 54(74):493-8. PubMed ID: 17523306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
    Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of IgA, IgG and IgM immunoglobulins and of 10 other plasma proteins in patients with duodenal ulcer treated with ranitidine].
    Przybyłowski J; Bartelik S; Szrajer J; Kolus D
    Wiad Lek; 1993; 46(1-2):9-13. PubMed ID: 8249388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum protein fractions in patients with laryngeal cancer undergoing radiation therapy. Possibility as a prognostic factor].
    Onizuka K; Migita S; Yamada H; Matsumoto I
    Fukuoka Igaku Zasshi; 1999 Feb; 90(2):46-58. PubMed ID: 10199063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.